In addition, Lin et al. 53 found that hypermethylation of CDH11 abnormal promoter in bladder cancer (BCA) cells led to the epigenetic inactivation of CDH11, and BCA with high CDH11 expression had poor prognosis 54. The gene discussed is CDH11; the disease is urinary bladder carcinoma.